Advagraf + Prograf + Corticosteroid + Mycophenolate mofetil

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

de Novo Kidney Transplantation

Conditions

de Novo Kidney Transplantation

Trial Timeline

Apr 1, 2012 โ†’ Jun 1, 2012

About Advagraf + Prograf + Corticosteroid + Mycophenolate mofetil

Advagraf + Prograf + Corticosteroid + Mycophenolate mofetil is a approved stage product being developed by Astellas Pharma for de Novo Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT01742624. Target conditions include de Novo Kidney Transplantation.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01742624ApprovedCompleted